Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: "At a minimum, the reporter could have found out how much the master used in the study typically charges and how much the DVD costs. Still, unlike most of the stories, this reporter did write, ""Dr. Shmerling said that though tai chi is inexpensive compared with other treatments, some patients would reject such an alternative therapy."" The story presents the evidence in relative terms. It would have been nice to see the absolute numbers. Still, it’s easy to calculate roughly what one third of 33 would be and one sixth would be. Essentially about 11 people stopped taking drugs after tai chi, and 5 or 6 stopped using other therapies. That’s not a huge difference, but, because there was any improvement, the researchers and the journal were understandably curious and hoping the study might spark more research. A big point of the story is that tai chi would be a much less onerous therapy with no harmful side effects. It is difficult to imagine that twice-weekly tai chi, like any other form of moderate exercise, would be harmful, but, at a minimum, the story could have reported upon the study’s adverse events registry. The journal article on which the story is based clearly discussed this. The story makes it clear early that the study is small and that more research would be needed in order to recommend tai chi as a therapy. There is no disease mongering and the description of the syndrome is the best of the five stories we reviewed. Most of the quotes in the story are from people not affiliated with the study. The story talks about how the study compared different alternatives, and it mentions, at least in passing, several other therapies. The story makes it clear that there are multiple versions of tai chi. It could have been more clear about how widely available it might be, especially in sparsely populated areas. The story says, ""Recent studies have suggested that tai chi, with its slow exercises, breathing and meditation, could benefit patients with other chronic conditions, including arthritis. But not all of these reports have been conclusive, and tai chi is hard to study because there are many styles and approaches."" This is all important context, succinctly presented. This story shows that you can pull together a lot of information and still keep the story tight. The story is very well reported and goes well beyond the original study, the editorial and any supporting materials. We were unable to locate a press release about the study."

Answer: Tai Chi Reported to Ease Fibromyalgia


Question: The council, which covers the city’s business center, was “reviewing (its) weed management methods and investigating other technologies”, a spokeswoman told Reuters in an email, a day after a strike by workers at a nearby council pressured it into trialing an alternative weedkiller. The City of Sydney council currently used Roundup “as a last resort ... when non-pesticide methods such as hand-weeding and mulching have been ineffective”, and began testing alternative products in late 2018, the spokeswoman added. Bayer says Roundup is safe and backed by several regulatory bodies, despite research that found its main ingredient glyphosate was probably carcinogenic. The German company has been hit by massive compensation payouts in the United States this year, over claims its product caused cancer, which have seen its shareprice to plummet. The prospect of Sydney council rethinking its ties to Roundup, a flagship product of U.S. agribusiness giant Monsanto Co until a buyout from Bayer last year, shows the pressure that grassroots campaigns and lawsuits are putting on governments about the product even as regulators declare it safe. “Because there’s a lot of emotion around it, local agencies may be moved to make a decision that’s made based on placating the general public rather than the available science,” said Ian Musgrave, a molecular pharmacologist and toxicologist at University of Adelaide. “We should be making decisions on safety based on actual science, not based on our fear or dismay of megacorporations.”  Earlier this week, Blacktown City Council in Sydney’s west agreed to trial an alternative to Roundup after a worker strike over the product left 40,000 garbage bins unemptied. Another four councils around Sydney previously quit using Roundup over possible links to cancer. Last month, an Australian gardener filed the country’s first lawsuit against Bayer, accusing Monsanto of causing him harm from exposure to glyphosate via decades of using Roundup. A Bayer spokesman said the company “encourages constructive dialogue with our stakeholders to build a broader trust in science”. The company had published “extensive research which supports our products’ safety” and was “committed to ensuring our customers continue to have access to these critical products as part of their sustainable agricultural activities”.

Answer: Sydney's city council reviews use of Bayer's Roundup weed killer amid cancer fears.


Question: E-cigarettes were invented about a decade ago by a Chinese medical researcher and the country supplies nearly all global demand. Puffing on the devices, or vaping, is surging worldwide, but it forms only a tiny part of China’s 1.2 trillion yuan (about $200 billion) cigarette business. Now, rising public awareness about the hazards of smoking, coupled with China’s hardening stance on smoking in public, is opening up an opportunity for e-cigarettes to make inroads into the world’s biggest tobacco market. “As more and more places become off limits to smoking, I find myself using e-cigarettes more often,” said Qu. Since starting using the product six years ago for health reasons, Qu has started selling e-cigarettes himself, expanding the business from exports to the domestic market this year. E-cigarettes are mostly sold online in China, where government regulation around the product is still lax. Countries like Singapore and Brazil currently ban e-cigarettes. Centered in the southern metropolis of Shenzhen, Chinese manufacturers including Shenzhen Smoore Technology, FirstUnion Group, Shenzhen Seego Technology Co Ltd and Ruyan Tech make around 95 percent of the world’s e-cigarettes, slim, battery-powered metal tubes that turn nicotine-laced liquid into vapour that is inhaled. Vaping is potentially a healthier alternative to smoking as the absence of combustion averts some of the harmful side-effects of tobacco smoke. But a big issue is the lack of long-term scientific evidence to support the safety and effectiveness of e-cigarettes, prompting critics like the British Medical Association to warn of the dangers of their unregulated use. Nevertheless, the e-cigarettes market is growing fast, although it is still only a tiny proportion of the global tobacco business. Last weekend, Hollywood stars Leonardo DiCaprio and Julia Louis-Dreyfus were seen smoking e-cigarettes at the globally televised Golden Globes awards ceremony. Some analysts predict e-cigarettes could outsell conventional cigarettes within a decade, particularly as Big Tobacco grapples with declining sales due to government regulation and health-aware consumers. E-cigarette sales in the United States grew at 115 percent each year between 2009 and 2012, and could grow us much as 240 percent this year, according to experts. The global e-cigarette market could increase fivefold to $10 billion by 2017, according to some estimates. For Chinese manufacturers of e-cigarettes, while the export market is surging, the domestic potential is tantalizing. Even a tiny portion of its 300 million-plus smokers would offer an attractive prize. In 2012, Chinese smoked a total of 2.46 trillion cigarettes - 4.8 per person, per day - and the country accounts for one-third of global consumption. “The harsher control of tobacco is great news for electric cigarettes,” said Lai Baosheng, general manager of e-cigarette maker Smoore, adding lax smoking rules in China had previously slowed the development of the business. Beijing has moved to clamp down on smoking, reinforcing a ban on officials smoking in public and increasing the price of tobacco by 5 percent this month. Health authorities said they would enforce a ban on smoking in public places nationwide this year - a law that has long been in the works. Smoore shipped over 100 million e-cigarettes to mostly Europe and the United States in 2013 with a sales value of 800 million yuan, double the level a year before, although Lai says the company is starting to eye the opportunity within China as smoking rules harden. Analysts say China’s domestic market would have to eventually open up to e-cigarettes. “There’s an unavoidable logic here that eventually no one will smoke regular tobacco on this planet,” said Shane MacGuill, London-based tobacco analyst at Euromonitor. “China won’t be able to become a kind of ghetto of tobacco, so there will have to be some movement towards an alternative, though how soon it’s going to happen I’m not sure. It will happen but it will take longer.”  Tobacco companies such as British American Tobacco Plc and Philip Morris International Inc as well as independent U.S. firms already source e-cigarettes from China. But e-cigarettes could also give them entry into the Chinese market - currently tobacco sales in China are largely governed by a state monopoly. Tobacco imports made up less than 1 percent of China’s market in 2012, according to Euromonitor, with the China National Tobacco Corporation dominating 98 percent of the domestic market, according to a paper from Brookings. E-cigarettes offer a potential route into China’s closely controlled tobacco market for brands such as Lorillard Inc’s blu e-cigarette, Philip Morris parent Altria’s MarkTen, BAT’s Vype or Reynolds American Inc’s Vuse. With China’s large state-owned tobacco firms largely steering clear of e-cigarettes - only one has made an obvious mention of looking into the technology - global Big Tobacco could target wealthier, more health-conscious smokers in China’s urban centers. But regulation of China’s e-cigarettes market is still in flux, and there are serious obstacles, not least China’s reluctance to risk losing the massive tax revenues currently derived from regular tobacco. The country could also decide to control any e-cigarette market as strictly as it does the traditional tobacco industry, leaving little room for outside players. “Nonetheless, I think it has to be seen as a potential way in to the Chinese market,” said Eddy Hargreaves, tobacco analyst at Cannacord Genuity. “The potential generally is huge and we’d expect it (to catch on in China), albeit it at a slower rate to the United States and Europe.” ($1 = 6.0412 Chinese yuan)

Answer:
"Vaping"" a slow burner in China, world's maker of e-cigarettes."